STOCK TITAN

SAB Biotherapeutics: Balyasny reports 7.94% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

SAB Biotherapeutics, Inc. (SABS) is the issuer; Balyasny Asset Management L.P., BAM GP LLC, Balyasny Asset Management Holdings LP, Dames GP LLC and Dmitry Balyasny each reported beneficial ownership of 7,225,439 shares, or 7.94% of the class.

The reported position consists of 3,760,439 shares and 3,465,000 shares issuable upon exercise of 34,650 warrants. The warrants are subject to a 9.99% beneficial ownership limit that prevents exercise to the extent it would put the holder above that percentage. The 7.94% calculation uses 90,986,368 shares outstanding as of August 3, 2026.

Beneficial ownership 7,225,439 shares Each reporting person; reported as 7.94% of the class
Ownership percentage 7.94% Based on 90,986,368 shares outstanding as of August 3, 2026
Shares held 3,760,439 shares Part of the reported beneficial ownership amount
Shares issuable under warrants 3,465,000 shares Part of the reported beneficial ownership amount
Warrants 34,650 warrants Warrants exercisable for the reported issuable shares
Beneficial ownership limit 9.99% Warrant exercise limitation
Shares outstanding 90,986,368 shares As of August 3, 2026
Beneficial Ownership Limitation technical
"subject to the Beneficial Ownership Limitation"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
sole dispositive power technical
"has the sole power to dispose or to direct the disposition"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
investment manager financial
"position as the investment manager of Atlas Diversified Master Fund"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SABS shares did Balyasny Asset Management report beneficially owning?

Balyasny Asset Management L.P. and the four other reporting persons each reported beneficial ownership of 7,225,439 shares, representing 7.94% of the class.

How many SABS shares were issuable under the reported warrants?

The reported position included 3,465,000 shares issuable upon exercise of 34,650 warrants, alongside 3,760,439 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





78397T202

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



BALYASNY ASSET MANAGEMENT L.P.
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
BAM GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Balyasny Asset Management Holdings LP
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Dames GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Dmitry Balyasny
Signature:/s/ Dmitry Balyasny
Name/Title:Dmitry Balyasny / Self
Date:11/16/2026

Keep reading